Skip left side navigation and go to content

NHLBI Recovery Act Funding and Policies

The NHLBI's funding plan strikes an important balance between increasing the number of investigator-initiated research grants and commitment to signature projects through the following mechanisms:

All Recovery Act awards will come with special reporting requirements that demonstrate how the project meets the objectives of the Recovery Act. (See the ‘overview’ section for fund plan allocations.)

Note: The NHLBI can fund only an extremely small number of contracts and does not plan to fund Competitive Revision Awards (competitive supplements).


NHLBI Research Grants: Expansion of FY 2008 and FY 2009 paylines*

The following proposals were funded by the NHLBI:

  • Highly meritorious investigator-initiated (R01) applications and similar mechanisms that ranked from the 15.1 through the 25 percentile and are capable of making significant advances with a two-year grant.
  • Early-stage investigators up to the 35th percentile. The first two years are being paid for with Recovery Act funds. The remaining years will be funded using usual appropriated funds.
  • New investigator-initiated (R01) applications that ranked from the 20.1 to the 30.0 percentile and are capable of making significant advances in two years.

*Note: Eligible applicants were notified by the NHLBI.



NHLBI Participation in NIH-Wide Recovery Act RFAs (Closed)



Last Updated: February 16, 2011




Other Important Links


Information from the White House and President Obama

Recovery Information from Health and Human Services



share your recovery act story


  • Did you get Recovery Act funding? Do you have a great story to tell? Let us know about it! E-mail nhlbi_news@nhlbi.nih.gov.
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon

Steven Kelsen, M.D.
Professor of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, Temple University School of Medicine, Philadelphia, Salim Merali, Ph.D. Associate Professor of Biochemistry; Director of the Proteomics Core, Temple University School of Medicine, Philadelphia, Pennsylvania Karina Davidson, Ph.D.; The Herbert Irving Associate Professor of Medicine and Psychiatry and Director of the Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, New York Picture of Dr.Shuir with two other doctors Photo of Eric Schmidt Image of map; This map highlights a sampling of the NHLBI's support of its scientific community through the American Recovery and Reinvestment Act.